News

FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs
The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN ...
US patients struggle as weight-loss drug discounts fall short
After years of easily available, cheap copies of Eli Lilly's and Novo Nordisk's highly effective weight-loss drugs, some U.S.
Trump administration proposes cutting FDA budget by 5.5%
The Trump administration is proposing a $6.8 billion budget request for the U.S. Food and Drug Administration for the 2026 ...
FDA panel is split on updates to COVID shots as questions loom for fall vaccinations
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...
Trump administration proposes cutting Food and Drug Administration budget by 5.5%
The Trump administration is proposing a $6.8 billion budget request for the U.S. Food and Drug Administration for the 2026 ...
RFK Jr.'s MAHA report raises concerns about vaccines, American foods and prescription drugs
A new government-issued report reflects some of the most controversial views on vaccines, the nation’s food supply, ...
RFK Jr.’s MAHA report targets food, drug, tech industries: Key takeaways
The Trump administration issued its long-awaited Make America Healthy Again (MAHA) Commission report Thursday, hammering ...
Amid compounding crackdown, US patients struggle as weight-loss drug discounts fall short
(Reuters) -After years of easily available, cheap copies of Eli Lilly's and Novo Nordisk's highly effective weight-loss drugs ...
The Food Recall System Is Broken, and Experts Say We’re All at Risk
On paper, the U.S. food recall system looks effective. But experts say its success depends on a communication chain that ...
STAT20h
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...
STAT41m
GSK drug’s new approval sets up competition with Dupixent
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.
Changes are happening around COVID-19 vaccines: Here's what to know
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.